The discovery of H. pylori is the most important development in gastroduodenal disease this
century. It has completely changed our understanding of conditions that occur in the upper …

Helicobacter pylori infection still represents a major health issue, especially in developing
countries, with an estimate of 4 billion of infected subjects in 2015. The increase of antibiotic …

An effective Helicobacter pylori therapy reliably provides high cure rates in infections with
susceptible strains. It is possible to predict the efficacy of any regimen if one knows the …

Helicobacter pylori is recognized to be a serious pathogen, but there is still controversy as to
who should be treated. There is consensus for treatment of Helicobacter‐positive peptic …

Although Helicobacter pylori infection is both a common and a serious bacterial infection,
antimicrobial therapies have rarely been optimized, are prescribed empirically, and provide …

In addition to its role in gastric conditions, Helicobacter pylori has been found to contribute to
the development of several non-gastric issues in recent years. Eradication therapy is the …

SUMMARY The Hp-EuReg report highlights practice variability but also marks the slow
transition of H. pylori therapy to therapies based on the principles of antimicrobial …

Important progress has been made in the management of Helicobacter pylori infection and
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …

Background: Consensus guidelines recommend that patients with peptic ulcer disease, and
other causes of dyspepsia, should be treated with Helicobacter pylori eradication regimens …

Background Infection with Helicobacter pylori (H. pylori) is a major pathogenic factor for
gastroduodenal ulcer disease and gastric carcinoma, as well as for other types of gastric …